ERα expression is upregulated in high-grade prostatic intraepithelial neoplasia (11%, 43%, 61%, and 94% in HGPIN, Gleason grade 4, grade 5, and recurrent adenocarcinoma, respectively, after therapy) (183). The gene discussed is ESR1; the disease is prostate intraepithelial neoplasia.